Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Cambridge-based Fulcrum Therapeutics said it will aim to launch a large clinical trial in the second half of 2026 to prove ...

About 100,000 people in the U.S. have sickle cell disease, a condition that primarily affects people of color, the CDC says.

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Uganda is among the countries with the highest burden of the disease, with an estimated 33,000 babies born each year carrying the sickle cell trait or disease. For thousands of families across Uganda, ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Five studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition reveal new ...

Dear Doctor, I am negative, and she is positive, so I had another test, which proved that she did not have sickle cell disease, and so we went ahead and got married.

Exagamglogene autotemcel helped children with beta thalassemia achieve transfusion independence and prevented vaso-occlusive crises among those with sickle cell disease in a pair of phase 3 ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...